- Letter of Intent terminated between ABL Texcell Diagnostics, Vela Diagnostics Holding, and Advanced Biological Laboratories.
ABL Texcell Diagnostics terminated the letter of intent to acquire Vela Diagnostics' operations in Singapore and the United States. The deal, announced September 21, 2026, will not proceed. The company continues its development strategy.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.